Researchers at Israel’s Bar-Ilan University and the IDC in Herzliya have used brainwaves of humans under strain, to control the release of medicine by tiny robots made from shells made of DNA.  The technique could be used (for example) to … Continue reading →

The amazing story of how Moti’s family realized that, despite the paralysis from his stroke, Moti was still there.  Now he uses the Israeli device Click2Speak to take part in conversations.  And he says that he’s happy! http://www.ezermizion.org/blog/is-he-still-there/

Israel’s DreaMed Diabetes is developing a decision support technology platform called the Advisor to determine optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes.  DreaMed has just raised $3.3 million for development. http://www.prnewswire.com/news-releases/dreamed-diabetes-raises-33-million-from-norma-investments-and-a-strategic-investor-300303138.html

I reported previously (Jun 13) that Israel’s AV Medical had completed trials of its unique balloon catheter that allows simultaneous angioplasty and fluid injection.  AV Medical has just commenced using Chameleon on patients in the US. http://www.a-vmedical.com/wp-content/uploads/2016/07/Chameleon-First-US-Cases-7-18-16-PDF.pdf

Israeli startup Vensica Medical is developing the ‘VensiCare, a painless needle-free ultrasound catheter system to deliver treatments for overactive bladder, bladder cancer and interstitial cystitis.  Vensica has just raised $500,000 for R&D and completion of device design. http://vensica.com/bladder-treatment-co-vensica-raises-500000-2/ https://www.youtube.com/watch?v=HH7078lg7EY http://www.globes.co.il/en/article-overactive-bladder-treatment-co-vensica-medical-raises-500000-1001140530

Israeli-based NRGene is the only company in the world to map the genome for bread, pasta and wild emmer wheat.  Now it is turning its attention to the human genome in order to help diagnose genetic disorders at an early … Continue reading →